Parallel Fluidics, the fastest microfluidic device manufacturer in the world, announced the close of its $7M seed round, led by J2 Ventures with participation from 8VC and Praxis. The funding will...
Plus Therapeutics, Inc, a clinical-stage pharmaceutical company developing targeted radiotherapeutics for central nervous system (CNS) cancers, and SpectronRx, a leading radiopharmaceutical contract developer and...
Microbiologics, a global biotechnology leader specializing in infectious disease reference materials and contract research services, is excited to announce the acquisition of SensID, a leading...
CS Genetics, a leader in next-generation single-cell genomics, announced the launch of SimpleCell 3' Gene Expression kits, its first commercial offering designed for accessible...
SOPHiA GENETICS, a cloud-native healthcare technology leader in data-driven medicine, announced the next step in the partnership between the Company and Genomenon, a leading...
